Also see: ADP, Amdocs, Cree: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (TheStreet) -- STOCK COMMENTS / EPS CHANGES
Apple (AAPL) estimates were increased through 2012 at Needham. Company should see better iPad and Mac shipments, Needham said. Maintain $450 price target.Cytec (CYT) estimates, target were cut through 2012 at Jefferies. Company could face further weakness in its coatings business, Jefferies said. Buy rating and new $64 price target. DuPont (DD) estimates were increased at Jefferies through 2012. Company is realizing higher TiO2 prices, Jefferies said. Buy rating and $64 price target. Forest Laboratories (FRX) estimates, target were increased at Credit Suisse. Shares now seen reaching $46, and estimates were also increased on M&A interest by larger peers. Credit Suisse said. Garmin (GRMN) estimates, target were lowered at Goldman Sachs. Shares now seen reaching $30. Estimates also cut, following the warning from TomTom, Goldman said. Neutral rating. Grainger (GWW) estimates, target were raised at UBS. Shares now seen reaching $156. Estimates also increased on good opportunities on margins, UBS said. Neutral rating. Huntsman (HUN) estimates, target were raised at Jefferies. Shares now seen reaching $26. Estimates also increased, given higher TiO2 prices, Jefferies said. Buy rating. Johnson Controls (JCI) estimates, target were increased at Piper Jaffray. Shares now seen reaching $51. Estimates were also increased on stronger-than-expected start-stop battery demand, Piper Jaffray said. Overweight rating. Jacobs Engineering (JEC) estimates, target cut at UBS. Shares now seen reaching $45. Estimates also lowered, as macro pressures remain UBS said. Neutral rating. Marathon Oil (MRO) estimates were boosted through 2013 at UBS. Improved refining margin outlook, UBS said. Maintain Buy rating and $60 price target. Teva Pharmaceutical (TEVA) estimates were lowered through 2012 at Jefferies. Stock is down 16% over the past year, even though the company has made positive strategic moves, Jefferies said. Hold rating and $53 price target. End of report.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV